|
|
| MRD / Regn No. |
: 20190000505 |
Date |
: 23/07/2026 |
| Patient Name |
: Nijamudeen Pakir Rowther |
Age & Gender |
: 70 Yrs. / Male |
| Contact No. |
: 9629641879 |
UHID |
: |
| Ht / Wt / BMI |
: 165.2 / 77.4 / 28.36 |
BP S / BP D |
: 126 / 79 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
CAD (04/Sep/2019) | TYPE 2 DM (04/Sep/2019) | HEART FAILURE STAGE B (06/Dec/2022) | DYSLIPIDEMIA (13/Aug/2024) | DIABETIC CELLULITIS (17/Jun/2025) | |
|
Subjective |
: |
HAS CELLULITIS
|
|
Objective |
: |
DRY SKIN |
|
Analysis |
: |
CAD,DIABETIC RETINOPATHY,HEART FAILURE STAGE B,TYPE 2 DM,DISTAL SENSORY NEUROPATHY,DYSLIPIDEMIA |
|
Plan |
: |
ADD SEMAGLUTIDE,SEE ME IN 1 MONTH WITH TESTING |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 206 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.80 % | POST PRANDIAL GLUCOSE (2HPP): 308 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 44 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 47 mg/dL | TGL TRIGLYCERIDE: 60 mg/dL | TOTAL CHO/HDL RATIO: 2.34 | TOTAL CHOLESTEROL: 103 mg/dl | VLDL: 12 mg/dl | A\G RATIO: 1.3 g/dl | ALBUMIN (SERUM): 4.33 g/dL | ALKALINE PHOSPHOTASE: 80 IU/L | DIRECT BILIRUBIN: 0.39 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 14 U/L | GLOBULIN: 3.36 g/dl | INDIRECT BILIRUBIN: 0.51 | SGOT (AST): 15 U/L | SGPT (ALT): 10 IU/L | TOTAL BILIRUBIN: 0.90 mg/dL | TOTAL PROTEIN: 7.69 g/dl |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
EMPAGLIFLOZIN 25 MG
JARDIANCE 25 MG
Medicine For DIABETES HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
2 |
TELMISARTAN 80 MG
ERTIEL 80 MG
Medicine For HYPERTENSION |
PO |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
3 |
TABLET IMEGLIMIN 500 MG
IMEXTOR
Medicine For GLUCOSE CONTROL |
PO |
1-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
4 |
TABLET PREGABALIN SR 75 MG
PREGALIN SR 75 MG
Medicine For NEUROPATHY |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
5 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
6 |
INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL |
SQ |
0-0-28 UNITS |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
7 |
CAPSULE SEMAGLUTIDE
SEMASIZE 0.25
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING VISUAL DISTURBANCE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 24/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |